Rheumatoid Arthritis Resource Center

Could Patients’ Expectations Impact Clinical Response to DMARDs in Rheumatoid Arthritis?

Could Patients’ Expectations Impact Clinical Response to DMARDs in Rheumatoid Arthritis?

A study observed a correlation between patients’ expectations toward newly induced disease-modifying antirheumatic drug (DMARD) therapies and clinical response among patients with rheumatoid arthritis...
rheumatic disease

Patients with Rheumatic Disease Are Protecting Themselves from COVID-19—But At What Cost?

Patients with chronic rheumatic diseases (CRD) had much lower seroprevalence of SARS-CoV-2 antibodies compared to blood donors, but had higher rates of depression, increased...
nsaid, dr., flu, FDA, Arthritis Medication Comparison, Expert Interviews: Rheum Round-up, PROs, Rheum Round-up: Abatacept vs. Other bDMARDs in RA, OA and Discrimination, and more

Rheum Round-up: Interviews—Dr. Woody on Unmet Needs in Pain and Inflammation, Dr. Hernandez on...

DocWire News recently spoke with Dr. Jim Woody, CEO of 180 Life Sciences, a company that develops new treatments for inflammation. Dr. Woody and his team...
Foot and Ankle Problems Still Plague Patients with Rheumatoid Arthritis Even Without Tender, Swollen Joints

Foot and Ankle Problems Still Plague Patients with Rheumatoid Arthritis Even Without Tender, Swollen...

Even if they do not present with tender and swollen joints per the 28-joint count, patients with rheumatoid arthritis (RA) still suffer from foot...
therapies, tocilizumab, rheum, RA, keenan, autoimmune, tofacitinib, telemedicine, covid-19, Hydroxychloroquine, Secukinumab, interview, rheumatologists, rheumatologist, arthroplasty, arthritis, rheumatic, ixekizumab, RA, rheumatoid, FDA, Rheum Round-up: Five RA Drugs Compared, Two THA Approaches, and more

Rheum Round-up: Tocilizumab and Diverticulitis Risk, Pulmonary Arterial Hypertension With Connective Tissue Disease, and...

Tocilizumab was associated with a greater risk for diverticulitis and gastrointestinal perforation (GIP) compared to rituximab and abatacept in patients with rheumatoid arthritis (RA)...
Tocilizumab Increases Risk of Diverticulitis Compared to Rituximab and Abatacept in Rheumatoid Arthritis

Tocilizumab Increases Risk of Diverticulitis Compared to Rituximab and Abatacept in Rheumatoid Arthritis

Tocilizumab was associated with a greater risk for diverticulitis and gastrointestinal perforation (GIP) compared to rituximab and abatacept in patients with rheumatoid arthritis (RA)...
Oral Microbiome Different for Patients with Rheumatoid Arthritis

Oral Microbiome Different for Patients with Rheumatoid Arthritis

Patients with rheumatoid arthritis (RA) and those who are at high risk for the disease had a distinctly different oral microbiome compared to healthy...

Curated Journal Reading List